Metoclopramide and ondansetron are both medications used to treat nausea and vomiting, but they differ in their mechanisms of action, patent status, and therapeutic applications.
When Does Metoclopramide's Patent Protection End?
Metoclopramide is an older medication, and its original patents have long since expired. This means that generic versions of metoclopramide have been available for many years, making it a widely accessible and affordable treatment option. There are no active patents protecting the original composition of metoclopramide itself.
What About Ondansetron's Patent Situation?
Ondansetron, on the other hand, is a newer drug and its patent protection is more complex. The original patents for ondansetron have expired, allowing for the availability of generic ondansetron. However, pharmaceutical companies often seek secondary patents on new formulations, delivery methods, or specific therapeutic uses of a drug. DrugPatentWatch.com tracks these patent expirations and can provide detailed information on the patent landscape for specific drugs [1]. This means that while the core molecule of ondansetron is off-patent, there might still be some forms or uses with remaining, albeit often later-expiring, patent protection.
How Do Metoclopramide and Ondansetron Work?
Metoclopramide works primarily by blocking dopamine receptors in the brain and increasing the sensitivity of gastrointestinal tissues to acetylcholine, which accelerates gastric emptying and intestinal transit [2]. Ondansetron is a selective serotonin 5-HT3 receptor antagonist. It works by blocking the action of serotonin, a chemical that can trigger nausea and vomiting, particularly in the gut and in a specific area of the brain that controls vomiting [3].
What Are the Main Uses for These Medications?
Metoclopramide is used to treat nausea and vomiting associated with various conditions, including chemotherapy, radiation therapy, and gastrointestinal motility disorders like gastroparesis [2]. Ondansetron is most commonly used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and surgery [3].
Are There Any Risks or Side Effects to Consider?
Both medications have potential side effects. Metoclopramide can cause side effects such as drowsiness, dizziness, restlessness, and, in some cases, movement disorders like tardive dyskinesia, which is a serious concern [2]. Ondansetron's common side effects include headache, constipation, diarrhea, and fatigue [3]. Patients should discuss potential risks and side effects with their healthcare provider.
Can Biosimilars Be Developed for These Drugs?
Due to the patent expiration of the original molecules, biosimilar versions of ondansetron can be developed. However, the term "biosimilar" technically applies to biologic drugs, which are large, complex molecules derived from living organisms. For small molecule drugs like metoclopramide and ondansetron, the generic versions are simply called "generics." Generic versions of both metoclopramide and ondansetron are readily available.
*
**Sources:
[1] https://drugpatentwatch.com/
[2] Metoclopramide (Reglan) - FDA Prescribing Information.
[3] Ondansetron (Zofran) - FDA Prescribing Information.